HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yannick Allanore Selected Research

Interleukin-6 (Interleukin 6)

10/2020Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
7/2014Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
6/2013IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yannick Allanore Research Topics

Disease

109Systemic Scleroderma (Systemic Sclerosis)
12/2023 - 01/2003
47Fibrosis (Cirrhosis)
03/2024 - 07/2006
30Rheumatoid Arthritis
12/2023 - 03/2006
30Interstitial Lung Diseases (Interstitial Lung Disease)
12/2023 - 06/2008
20Diffuse Scleroderma (Progressive Systemic Sclerosis)
03/2024 - 06/2004
16Inflammation (Inflammations)
12/2023 - 03/2006
14digital ulcers
12/2023 - 03/2010
14Pulmonary Hypertension
10/2022 - 07/2006
13Arthritis (Polyarthritis)
08/2023 - 07/2003
11Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2023 - 01/2010
9Rheumatic Diseases (Rheumatism)
11/2023 - 12/2013
9Infections
08/2023 - 07/2012
9Connective Tissue Diseases (Connective Tissue Disease)
08/2023 - 05/2008
9Pulmonary Arterial Hypertension
01/2020 - 05/2008
6Autoimmune Diseases (Autoimmune Disease)
08/2023 - 03/2011
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 11/2011
6Neoplasms (Cancer)
11/2021 - 07/2006
6Disease Progression
11/2020 - 01/2016
5Synovitis
01/2023 - 01/2010
5Pain (Aches)
11/2022 - 05/2005
5Vascular Remodeling
01/2022 - 01/2011
4Ulcer
12/2023 - 02/2008
3Hypertension (High Blood Pressure)
09/2023 - 01/2016
3COVID-19
08/2023 - 01/2022
3Hypoxia (Hypoxemia)
01/2016 - 08/2011
3Telangiectasis (Telangiectasia)
06/2014 - 11/2013
2Psoriatic Arthritis
11/2023 - 12/2014
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
10/2023 - 06/2019
2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2023 - 12/2014
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2019
2Lung Diseases (Lung Disease)
01/2022 - 03/2020
2Cicatrix (Scar)
01/2022 - 01/2015
2Respiratory Insufficiency (Respiratory Failure)
01/2021 - 02/2012
2Pneumonia (Pneumonitis)
01/2021 - 01/2019
2Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 07/2009
2Wounds and Injuries (Trauma)
05/2020 - 12/2016
2Raynaud Disease (Raynaud's Disease)
01/2020 - 06/2014
2Ankylosing Spondylitis
01/2020 - 05/2012
2Idiopathic Pulmonary Fibrosis
01/2020 - 12/2018
2Heart Failure
11/2019 - 01/2014
2Chronic Disease (Chronic Diseases)
02/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

20Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2008
17AntibodiesIBA
12/2023 - 08/2006
17AutoantibodiesIBA
11/2022 - 01/2005
15Rituximab (Mabthera)FDA Link
12/2023 - 01/2008
13CollagenIBA
08/2023 - 01/2003
12Bleomycin (Blenoxane)FDA LinkGeneric
11/2023 - 03/2011
12nintedanibIBA
06/2023 - 01/2021
10C-Reactive ProteinIBA
12/2023 - 08/2008
9tocilizumab (atlizumab)FDA Link
06/2023 - 07/2013
8Infliximab (Remicade)FDA Link
01/2021 - 06/2003
8Abatacept (Orencia)FDA Link
12/2020 - 07/2013
7Methotrexate (Mexate)FDA LinkGeneric
12/2023 - 07/2003
6anti-scl-70 autoantibodiesIBA
06/2023 - 07/2015
5riociguatIBA
03/2024 - 01/2017
5Biosimilar PharmaceuticalsIBA
11/2023 - 01/2018
5Etanercept (Enbrel)FDA Link
11/2023 - 07/2003
4EnzymesIBA
03/2024 - 09/2011
4Carbon MonoxideIBA
12/2023 - 01/2014
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2023 - 05/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2023 - 06/2008
4Antinuclear AntibodiesIBA
12/2021 - 01/2005
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 05/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015 - 07/2003
3Rheumatoid FactorIBA
12/2023 - 08/2008
3Anti-Citrullinated Protein AntibodiesIBA
01/2023 - 12/2014
3InterferonsIBA
11/2022 - 05/2010
3Interleukin-13IBA
12/2020 - 08/2006
3ametantrone (HAQ)IBA
10/2020 - 01/2017
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 06/2013
3Antirheumatic Agents (DMARD)IBA
03/2020 - 01/2018
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020 - 01/2013
3CytokinesIBA
01/2019 - 03/2014
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2017 - 05/2015
3Brain Natriuretic Peptide (Natrecor)FDA Link
11/2016 - 02/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 01/2004
3Hydroxyproline (4 Hydroxyproline)IBA
05/2015 - 03/2011
3erucylphosphocholineIBA
04/2013 - 11/2011
3Fibrillin-1IBA
04/2010 - 12/2007
3Proteins (Proteins, Gene)FDA Link
09/2008 - 05/2004
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2005 - 05/2004
2Messenger RNA (mRNA)IBA
03/2024 - 01/2022
2anticentromere antibodyIBA
10/2023 - 01/2011
2Immunosuppressive Agents (Immunosuppressants)IBA
08/2023 - 12/2013
2Chimeric Antigen ReceptorsIBA
08/2023 - 11/2021
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
06/2023 - 06/2016
2Monoclonal AntibodiesIBA
06/2023 - 06/2013
2Tyrosine Kinase InhibitorsIBA
06/2023 - 10/2022
2Semaphorins (Semaphorin)IBA
01/2023 - 01/2021
2Interleukin-2 (IL2)IBA
01/2022 - 01/2018
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2021 - 07/2006
2Immunomodulating AgentsIBA
01/2021 - 07/2006
2CT-P13IBA
01/2021 - 01/2021
2InterleukinsIBA
12/2020 - 01/2019
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2020 - 01/2019
2Iloprost (Ventavis)FDA Link
02/2019 - 12/2012

Therapy/Procedure

28Therapeutics
12/2023 - 07/2003
3Immunotherapy
06/2017 - 03/2014
2Liver Transplantation
10/2023 - 03/2010
2Injections
01/2022 - 05/2015